Product Description
Acellular Dermal Matrix/donor dermis (Sourced from: https://clinicaltrials.gov/ct2/history/NCT02360358?V_2=View)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: N/A
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Chantal Blok
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 2: Varicose Ulcer
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| TIS2012 | P2 |
Terminated |
Varicose Ulcer |
2015-12-01 |